ASTH vs SGRY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

ASTH

49.3
AI Score
VS
SGRY Wins

SGRY

59.5
AI Score

Investment Advisor Scores

ASTH

49score
Recommendation
HOLD

SGRY

60score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric ASTH SGRY Winner
Forward P/E 23.0415 18.3486 SGRY
PEG Ratio 0 1.66 Tie
Revenue Growth 48.5% 2.7% ASTH
Earnings Growth 110.5% 0.0% ASTH
Tradestie Score 49.3/100 59.5/100 SGRY
Profit Margin 1.1% -2.6% ASTH
Beta 1.00 1.00 Tie
AI Recommendation HOLD STRONG BUY SGRY

Relative Price Performance (Last 90 Days)

ASTH 1M: +6.1% · 3M: -4.7% SGRY 1M: -6.1% · 3M: -3.7%

Current Technical Phase

ASTH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 47.0 · Price: $37.98

SGRY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 49.2 · Price: $14.38

Fundamentals Snapshot

Metric ASTH SGRY
Market Cap
Forward P/E 10.7 22.9
Trailing P/E 46.4
Revenue (TTM)
Revenue Growth 0.5% 0.0%
Gross Margin 0.1% 0.2%
Operating Margin 0.0% 0.1%
EPS 0.82 -0.69
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, SGRY is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.